{"id":"W2005548106","doi":"10.1097/wco.0000000000000203","title":"Novel and imminently emerging treatments in relapsing–remitting multiple sclerosis","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"EMD Serono; IC Design Education Center; Multiple Sclerosis Society; Biogen","keywords":"Relapsing remitting; Medicine; Glatiramer acetate; Alemtuzumab; Tolerability; Multiple sclerosis; Intensive care medicine; Natalizumab; Ocrelizumab; Adverse effect; Pharmacology; Rituximab; Internal medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007199492,0.0005952039,0.002344178,0.001113815,0.00007389757,0.00002309597,0.0002083869,0.0003631357,0.00001135689],"category_scores_gemma":[0.001618178,0.0005049232,0.0002232267,0.0007148645,0.0001965416,0.00008733533,0.0005312721,0.001462548,0.00002389828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002619399,"about_ca_system_score_gemma":0.000239404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001029066,"about_ca_topic_score_gemma":0.00002316565,"domain_scores_codex":[0.9961836,0.0004004603,0.001162237,0.001049633,0.0004238539,0.0007801538],"domain_scores_gemma":[0.9981177,0.0007175942,0.0003648375,0.0004564284,0.00009722337,0.0002462387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009156053,0.0005103191,0.02036839,0.01129197,0.00007520692,0.00000694499,0.0002179562,0.000002574909,0.00001080272,0.000005586859,0.0008062863,0.9666124],"study_design_scores_gemma":[0.00581318,0.000402934,0.026382,0.03126153,0.0001439386,0.00009064299,0.00002735532,0.0004520934,3.327219e-7,0.000005110253,0.9350274,0.0003935191],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001323888,0.9931239,0.000009681938,0.0002652915,0.003253517,0.001852752,0.00005625209,0.00004568319,0.00006906407],"genre_scores_gemma":[0.0003546394,0.9982514,0.0001326829,0.00002052945,0.0004301771,0.0004761629,0.0002355118,0.00007984307,0.00001902347],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9662189,"threshold_uncertainty_score":0.9997402,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.373758277730524,"score_gpt":0.4498690152482297,"score_spread":0.0761107375177057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}